Silicon Valley to Sonogram: How a Startup’s AI Just Won the FDA’s Trust to Redefine Prenatal Care
Introduction In a landmark decision poised to reshape prenatal diagnostics, the U.S. Food and Drug Administration has greenlit an artificial intelligence tool designed to peer into the earliest stages of human life. The software, developed by 2026 TechCrunch Disrupt Battlefield champion BioticsAI, assists clinicians in identifying potential fetal abnormalities from standard ultrasound images. This clearance…

